Hello,
We're having some issues with footnotes in a table header (PDF generated
from DITA sources with DITA OT 1.8). In other tables, footnotes are listed
Ok if they are in different rows.
In this specific table, we have several footnotes in several cells of the
same row. In the topic.fo, the footnotes appear in the right order (see
sample below). In the PDF output (see attached screenshot) the footnotes
for each cell are in the right order but the list starts with the
footnotes of the last cell of the row and works the way back to the first
cell.
Since the topic.fo is Ok, I don't know what I could do to fix that in my
custom XSL. Any idea?
Thanks & regards,
<fo:table-header>
<fo:table-row background-color="#bfbfbf">
<fo:table-cell background-color="inherit" border-bottom-color=
"black" border-bottom-style="solid" border-bottom-width="1pt"
border-right-color="black" border-right-style="solid" border-right-width=
"1pt" border-top-color="black" border-top-style="solid" border-top-width=
"1pt" display-align="center" text-align="from-table-column()"><fo:block
end-indent="3pt" font-weight="bold" space-after="3pt"
space-after.conditionality="retain" space-before="3pt"
space-before.conditionality="retain" start-indent="3pt">TCI model,
<fo:block xmlns:opentopic-func="
http://www.idiominc.com/opentopic/exsl/function" xmlns:xs="
http://www.w3.org/2001/XMLSchema" background-color="transparent" color=
"black" font-size="10pt" font-style="normal" font-weight="normal"
line-height="1.2" space-after="4pt" space-before="8pt" text-align="start"
text-decoration="none" text-indent="0em" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang">IV drug </fo:block></fo:block></fo:table-cell>
<fo:table-cell background-color="inherit" border-bottom-color=
"black" border-bottom-style="solid" border-bottom-width="1pt"
border-right-color="black" border-right-style="solid" border-right-width=
"1pt" border-top-color="black" border-top-style="solid" border-top-width=
"1pt" display-align="center" text-align="from-table-column()"><fo:block
end-indent="3pt" font-weight="bold" space-after="3pt"
space-after.conditionality="retain" space-before="3pt"
space-before.conditionality="retain" start-indent="3pt">Marsh
<fo:inline/><fo:footnote><fo:inline baseline-shift="super" font-size="7pt"
font-weight="normal" keep-with-previous.within-line="always" text-align=
"start">7</fo:inline><fo:footnote-body><fo:list-block font-size="8pt"
font-weight="normal" line-height="1.2"
provisional-distance-between-starts="8mm" provisional-label-separation=
"2mm" start-indent="0pt" text-align="start" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang"><fo:list-item><fo:list-item-label end-indent="label-end()"
><fo:block text-align="right"><fo:inline baseline-shift="super" font-size=
"7pt" font-weight="normal" keep-with-previous.within-line="always"
text-align="start">7
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>B. Marsh, M. White, N. Morton,
G.N.C. Kenny. Pharmacokinetic model driven
infusion of propofol in children. <fo:inline font-style="italic">
British Journal of Anesthesia</fo:inline>. 1991, 67, pp.
41-48.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote>
<fo:inline/><fo:footnote><fo:inline baseline-shift="super"
font-size="7pt" font-weight="normal" keep-with-previous.within-line=
"always" text-align="start">8</fo:inline><fo:footnote-body><fo:list-block
font-size="8pt" font-weight="normal" line-height="1.2"
provisional-distance-between-starts="8mm" provisional-label-separation=
"2mm" start-indent="0pt" text-align="start" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang"><fo:list-item><fo:list-item-label end-indent="label-end()"
><fo:block text-align="right"><fo:inline baseline-shift="super" font-size=
"7pt" font-weight="normal" keep-with-previous.within-line="always"
text-align="start">8
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>M. M. Struys, et al. Comparison of
Plasma Compartment versus two Methods for Effect
Compartment-Target Controlled Infusion for Propofol. <fo:inline
font-style="italic">Anesthesiology</fo:inline>. 2000, 92,
pp. 399-406.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote>
<fo:inline/><fo:footnote><fo:inline baseline-shift="super"
font-size="7pt" font-weight="normal" keep-with-previous.within-line=
"always" text-align="start">9</fo:inline><fo:footnote-body><fo:list-block
font-size="8pt" font-weight="normal" line-height="1.2"
provisional-distance-between-starts="8mm" provisional-label-separation=
"2mm" start-indent="0pt" text-align="start" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang"><fo:list-item><fo:list-item-label end-indent="label-end()"
><fo:block text-align="right"><fo:inline baseline-shift="super" font-size=
"7pt" font-weight="normal" keep-with-previous.within-line="always"
text-align="start">9
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>J. H. Seo, et al. Influence of a
modified propofol equilibration rate constant (Ke0) on
the effect-site concentration at loss and recovery of
consciousness with the March model.
<fo:inline font-style="italic">Anaesthesia</fo:inline>, 2013.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote>
<fo:inline/><fo:footnote><fo:inline baseline-shift="super"
font-size="7pt" font-weight="normal" keep-with-previous.within-line=
"always" text-align="start">10</fo:inline><fo:footnote-body><fo:list-block
font-size="8pt" font-weight="normal" line-height="1.2"
provisional-distance-between-starts="8mm" provisional-label-separation=
"2mm" start-indent="0pt" text-align="start" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang"><fo:list-item><fo:list-item-label end-indent="label-end()"
><fo:block text-align="right"><fo:inline baseline-shift="super" font-size=
"7pt" font-weight="normal" keep-with-previous.within-line="always"
text-align="start">10
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>R.F. Simoni, et al. Clinical
Evaluation of two Ke0 in the same pharmacokinetic Propofol
Model: Study on Loss and Recovery of Consciousness. <fo:inline
font-style="italic">Review of Brasilian
Anesthesiology</fo:inline>. 61, 2011, 4, pp. 397-408.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote>
,<fo:block xmlns:opentopic-func="
http://www.idiominc.com/opentopic/exsl/function" xmlns:xs="
http://www.w3.org/2001/XMLSchema" background-color="transparent" color=
"black" font-size="10pt" font-style="normal" font-weight="normal"
line-height="1.2" space-after="4pt" space-before="8pt" text-align="start"
text-decoration="none" text-indent="0em" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang">Propofol</fo:block></fo:block></fo:table-cell>
<fo:table-cell background-color="inherit" border-bottom-color=
"black" border-bottom-style="solid" border-bottom-width="1pt"
border-right-color="black" border-right-style="solid" border-right-width=
"1pt" border-top-color="black" border-top-style="solid" border-top-width=
"1pt" display-align="center" text-align="from-table-column()"><fo:block
end-indent="3pt" font-weight="bold" space-after="3pt"
space-after.conditionality="retain" space-before="3pt"
space-before.conditionality="retain" start-indent="3pt">Schnider
<fo:inline/><fo:footnote><fo:inline baseline-shift="super" font-size="7pt"
font-weight="normal" keep-with-previous.within-line="always" text-align=
"start">11</fo:inline><fo:footnote-body><fo:list-block font-size="8pt"
font-weight="normal" line-height="1.2"
provisional-distance-between-starts="8mm" provisional-label-separation=
"2mm" start-indent="0pt" text-align="start" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang"><fo:list-item><fo:list-item-label end-indent="label-end()"
><fo:block text-align="right"><fo:inline baseline-shift="super" font-size=
"7pt" font-weight="normal" keep-with-previous.within-line="always"
text-align="start">11
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>T. W. Schnider, C. F. Minto, P. L.
Gambus, C. Andresen, D. B. Goodale, S.
L. Shafer, E. J. Youngs. The Influence of Method of Administration
and Covariates on the
Pharmacokinetics of Propofol in Adult Volunteers. <fo:inline
font-style="italic">Anesthesiology</fo:inline>. May 1998,
Vol. 88, 5.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote>
<fo:inline/><fo:footnote><fo:inline baseline-shift="super"
font-size="7pt" font-weight="normal" keep-with-previous.within-line=
"always" text-align="start">12</fo:inline><fo:footnote-body><fo:list-block
font-size="8pt" font-weight="normal" line-height="1.2"
provisional-distance-between-starts="8mm" provisional-label-separation=
"2mm" start-indent="0pt" text-align="start" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang"><fo:list-item><fo:list-item-label end-indent="label-end()"
><fo:block text-align="right"><fo:inline baseline-shift="super" font-size=
"7pt" font-weight="normal" keep-with-previous.within-line="always"
text-align="start">12
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>T. W. Schnider, et al. The Influence
of Age on Propofol Pharmacodynamics.
<fo:inline font-style="italic">Anesthesiology</fo:inline>. 1999,
90, pp. 1502-16.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote>
,<fo:block xmlns:opentopic-func="
http://www.idiominc.com/opentopic/exsl/function" xmlns:xs="
http://www.w3.org/2001/XMLSchema" background-color="transparent" color=
"black" font-size="10pt" font-style="normal" font-weight="normal"
line-height="1.2" space-after="4pt" space-before="8pt" text-align="start"
text-decoration="none" text-indent="0em" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang">Propofol</fo:block></fo:block></fo:table-cell>
<fo:table-cell background-color="inherit" border-bottom-color=
"black" border-bottom-style="solid" border-bottom-width="1pt"
border-right-color="black" border-right-style="solid" border-right-width=
"1pt" border-top-color="black" border-top-style="solid" border-top-width=
"1pt" display-align="center" text-align="from-table-column()"><fo:block
end-indent="3pt" font-weight="bold" space-after="3pt"
space-after.conditionality="retain" space-before="3pt"
space-before.conditionality="retain" start-indent="3pt">Minto
<fo:inline/><fo:footnote><fo:inline baseline-shift="super" font-size="7pt"
font-weight="normal" keep-with-previous.within-line="always" text-align=
"start">13</fo:inline><fo:footnote-body><fo:list-block font-size="8pt"
font-weight="normal" line-height="1.2"
provisional-distance-between-starts="8mm" provisional-label-separation=
"2mm" start-indent="0pt" text-align="start" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang"><fo:list-item><fo:list-item-label end-indent="label-end()"
><fo:block text-align="right"><fo:inline baseline-shift="super" font-size=
"7pt" font-weight="normal" keep-with-previous.within-line="always"
text-align="start">13
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>C. F. Minto, et al. Influence of Age
and Gender on the Pharmacokinetics and
Pharmacodynamics of Remifentanil. <fo:inline font-style="italic">
Anesthesiology</fo:inline>. 1997, Vol. 86, pp.
24-33.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote>
,<fo:block xmlns:opentopic-func="
http://www.idiominc.com/opentopic/exsl/function" xmlns:xs="
http://www.w3.org/2001/XMLSchema" background-color="transparent" color=
"black" font-size="10pt" font-style="normal" font-weight="normal"
line-height="1.2" space-after="4pt" space-before="8pt" text-align="start"
text-decoration="none" text-indent="0em" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang">Remifentanil</fo:block></fo:block></fo:table-cell>
<fo:table-cell background-color="inherit" border-bottom-color=
"black" border-bottom-style="solid" border-bottom-width="1pt"
border-right-color="black" border-right-style="solid" border-right-width=
"1pt" border-top-color="black" border-top-style="solid" border-top-width=
"1pt" display-align="center" text-align="from-table-column()"><fo:block
end-indent="3pt" font-weight="bold" space-after="3pt"
space-after.conditionality="retain" space-before="3pt"
space-before.conditionality="retain" start-indent="3pt">Gepts
<fo:inline/><fo:footnote><fo:inline baseline-shift="super" font-size="7pt"
font-weight="normal" keep-with-previous.within-line="always" text-align=
"start">14</fo:inline><fo:footnote-body><fo:list-block font-size="8pt"
font-weight="normal" line-height="1.2"
provisional-distance-between-starts="8mm" provisional-label-separation=
"2mm" start-indent="0pt" text-align="start" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang"><fo:list-item><fo:list-item-label end-indent="label-end()"
><fo:block text-align="right"><fo:inline baseline-shift="super" font-size=
"7pt" font-weight="normal" keep-with-previous.within-line="always"
text-align="start">14
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>E. Gepts et al. Linearity of
pharmacokinetics and model estimation of
sufentanil. <fo:inline font-style="italic">Anesthesiology
</fo:inline>. 1995, Vol. 83, pp.
1194-1204.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote>
,<fo:block xmlns:opentopic-func="
http://www.idiominc.com/opentopic/exsl/function" xmlns:xs="
http://www.w3.org/2001/XMLSchema" background-color="transparent" color=
"black" font-size="10pt" font-style="normal" font-weight="normal"
line-height="1.2" space-after="4pt" space-before="8pt" text-align="start"
text-decoration="none" text-indent="0em" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang">Sufentanil</fo:block></fo:block></fo:table-cell>
<fo:table-cell background-color="inherit" border-bottom-color=
"black" border-bottom-style="solid" border-bottom-width="1pt"
border-top-color="black" border-top-style="solid" border-top-width="1pt"
display-align="center" text-align="from-table-column()"><fo:block
end-indent="3pt" font-weight="bold" space-after="3pt"
space-after.conditionality="retain" space-before="3pt"
space-before.conditionality="retain" start-indent="3pt">Scott Kapilla
<fo:inline/><fo:footnote><fo:inline baseline-shift="super" font-size="7pt"
font-weight="normal" keep-with-previous.within-line="always" text-align=
"start">15</fo:inline><fo:footnote-body><fo:list-block font-size="8pt"
font-weight="normal" line-height="1.2"
provisional-distance-between-starts="8mm" provisional-label-separation=
"2mm" start-indent="0pt" text-align="start" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang"><fo:list-item><fo:list-item-label end-indent="label-end()"
><fo:block text-align="right"><fo:inline baseline-shift="super" font-size=
"7pt" font-weight="normal" keep-with-previous.within-line="always"
text-align="start">15
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>J. Scott, et al. <fo:inline
font-style="italic">Quantification of Narcotic Effect: the
comparative pharmacodynamics of fentanyl and alfentanil
</fo:inline>. 1985, Vol. 62, pp.
234-241.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote>
<fo:inline/><fo:footnote><fo:inline baseline-shift="super"
font-size="7pt" font-weight="normal" keep-with-previous.within-line=
"always" text-align="start">16</fo:inline><fo:footnote-body><fo:list-block
font-size="8pt" font-weight="normal" line-height="1.2"
provisional-distance-between-starts="8mm" provisional-label-separation=
"2mm" start-indent="0pt" text-align="start" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang"><fo:list-item><fo:list-item-label end-indent="label-end()"
><fo:block text-align="right"><fo:inline baseline-shift="super" font-size=
"7pt" font-weight="normal" keep-with-previous.within-line="always"
text-align="start">16
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>A. Kapila, et al. Measured
context-sensitive half-times of remifentanil and alfentanil.
<fo:inline font-style="italic">Anesthesiology</fo:inline>. 1995,
Vol. 83, pp. 968-975.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote>
<fo:inline/><fo:footnote><fo:inline baseline-shift="super"
font-size="7pt" font-weight="normal" keep-with-previous.within-line=
"always" text-align="start">17</fo:inline><fo:footnote-body><fo:list-block
font-size="8pt" font-weight="normal" line-height="1.2"
provisional-distance-between-starts="8mm" provisional-label-separation=
"2mm" start-indent="0pt" text-align="start" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang"><fo:list-item><fo:list-item-label end-indent="label-end()"
><fo:block text-align="right"><fo:inline baseline-shift="super" font-size=
"7pt" font-weight="normal" keep-with-previous.within-line="always"
text-align="start">17
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>Maitre PO, Vozeh S, Heykants J, et
al. Population pharmacokinetics of alfentanil: the
average dose-plasma concentration relationship and interindividual
variability in patients.
<fo:inline font-style="italic">Anesthesiology</fo:inline>.
1987;66:3-12.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote>
, <fo:block xmlns:opentopic-func="
http://www.idiominc.com/opentopic/exsl/function" xmlns:xs="
http://www.w3.org/2001/XMLSchema" background-color="transparent" color=
"black" font-size="10pt" font-style="normal" font-weight="normal"
line-height="1.2" space-after="4pt" space-before="8pt" text-align="start"
text-decoration="none" text-indent="0em" line-height-shift-adjustment=
"disregard-shifts" font-family="Helvetica, Arial Unicode MS, Tahoma,
Batang">Alfentanil<fo:inline/><fo:footnote><fo:inline baseline-shift=
"super" font-size="7pt" font-weight="normal"
keep-with-previous.within-line="always" text-align="start">18
</fo:inline><fo:footnote-body><fo:list-block font-size="8pt" font-weight=
"normal" line-height="1.2" provisional-distance-between-starts="8mm"
provisional-label-separation="2mm" start-indent="0pt" text-align="start"
line-height-shift-adjustment="disregard-shifts" font-family="Helvetica,
Arial Unicode MS, Tahoma, Batang"><fo:list-item><fo:list-item-label
end-indent="label-end()"><fo:block text-align="right"><fo:inline
baseline-shift="super" font-size="7pt" font-weight="normal"
keep-with-previous.within-line="always" text-align="start">18
</fo:inline></fo:block></fo:list-item-label><fo:list-item-body
start-indent="body-start()"><fo:block>The Alfentanil
pharmacokinetic model is only available as an option.
</fo:block></fo:list-item-body></fo:list-item></fo:list-block></fo:footnote-body></fo:footnote></fo:block></fo:block></fo:table-cell>
</fo:table-row>
</fo:table-header>
Annette-consultant Bouillin
IFU project lead for ONG - Assystem consultant
FRESENIUS VIAL SAS
Société par Actions Simplifiée
au capital de 15 344 534,75 euros
RCS Grenoble B 408 720 282
Le Grand Chemin
38590 Brézins - France
T : +33 4 76 67 57 04
F : +33 4 76 67 11 34
annette-consultant.bouillin@fresenius-kabi.com
www.fresenius-kabi.com
Ce message est à la seule attention du (ou des) destinataire(s)
attitré(s). Il peut contenir des informations confidentielles ou privées
et faire l'objet d'une protection par privilège juridique. Si vous n'êtes
pas un destinataire attitré, vous ne pouvez pas revoir, utiliser, copier
ou distribuer ce message ou ses pièces attachées. Si vous avez reçu cette
communication par erreur, merci de bien vouloir en aviser l'expéditeur par
retour de courriel et de détruire de votre ordinateur ce message ainsi que
les pièces attachées.
This e-mail message is intended solely for the use of the addressee and
may contain legally privileged and confidential information. If you are
not the intended recipient or his/her representative, please be advised
that any dissemination, distribution, copying, or the use of this message
or its attachments is strictly prohibited. If you have received this
message in error, please notify the sender immediately and please delete
this message and all attachments from your computer.
Par égard pour l'environnement, n’imprimez ce message que si nécessaire.
With regards to the environment, print this message only if necessary.
_______________________________________________
(*) To unsubscribe, please visit http://lists.renderx.com/mailman/options/xep-support
(*) By using the Service, you expressly agree to these Terms of Service http://w
ww.renderx.com/terms-of-service.html
This archive was generated by hypermail 2.1.8 : Tue Apr 14 2015 - 00:47:00 PDT
